Clinic Variation in the Cost-Effectiveness of Contingency Management

REFERENCES

• Petry NM, Pierce J, Stitzer ML, , et al. Prize-based incentives improve outcomes of stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005;62:1148–1156.
   PubMed Web of Science ®Google Scholar
• Peirce JM, Petry NM, Stitzer ML, , et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network Study. Arch Gen Psychiatry. 2006;63:201–208.
   PubMed Web of Science ®Google Scholar
• Higgins ST, Sigmon SC, Wong CJ, , et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003;60:1043–1052.
   PubMed Web of Science ®Google Scholar
• Rawson RA, Huber A, McCann M, , et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59:817–824.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000;68:1051–1061.
   PubMed Web of Science ®Google Scholar
• Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes and they will come: Contingency management for the treatment of alcohol dependence. J Consult Clin Psychol. 2000;68:250–257.
   PubMed Web of Science ®Google Scholar
• Petry NM, Tedford J, Austin M, Nich C, Carroll K, Rounsaville B. Prize reinforcement contingency management for treating cocaine user: how low can we go, and with whom? Addiction. 2004;99:349–360.
   PubMed Web of Science ®Google Scholar
• Petry NM, Martin B. Lower-cost contingency management for treating cocaine-abusing methadone patients. J Consult Clin Psychol. 2002;70:398–405.
   PubMed Web of Science ®Google Scholar
• Ritter A, Cameron J. Australian clinician attitudes towards contingency management: comparing down under with America. Drug Alcohol Depend. 2007;87:312–315.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ. Bridging the gap between research and practice in substance abuse treatment: a hybrid model linking efficacy and effectiveness research. Psychiatr Serv. 2003;54:333–339.
   PubMed Web of Science ®Google Scholar
• Petry NM. A comprehensive guide for the application of contingency management procedures in standard clinic settings. Drug Alcohol Depend. 2000;58:9–25.
   PubMed Web of Science ®Google Scholar
• Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–182.
   PubMed Web of Science ®Google Scholar
• Sindelar JL, Elbel B, Petry NM. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction. 2007;102:309–316.
   PubMed Web of Science ®Google Scholar
• French MT, Mausopf JA, Teague JL, Roland J. Estimating the dollar value of health outcomes from drug abuse interventions. Med Care. 1996;34:890–910.
   PubMed Web of Science ®Google Scholar
• Cartwright WS. Cost benefit and cost-effectiveness analysis of drug abuse treatment services. Eval Rev. 1998;22:609–636.
   PubMed Web of Science ®Google Scholar
• Cartwright WS. Cost-benefit analysis of drug treatment services: Review of the literature. J Ment Health Policy Econ. 2000;3:11–26.
   PubMedGoogle Scholar
• Barnett PG, Zaric GS, Brandeau ML. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction. 2001;96:1267–1278.
   PubMed Web of Science ®Google Scholar
• Jofre-Bonet M, Sindelar JL. Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment. J Behav Health Serv Res. 2004;31:229–241.
   Google Scholar
• Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addition treatments for illicit drug dependence: paradoxes with multivariate outcomes. Drug Alcohol Depend. 2004;73:41–50.
   PubMed Web of Science ®Google Scholar
• Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programs. 2nd ed. Oxford, UK: Oxford University Press; 1997.
   Google Scholar
• Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford, UK: Oxford University Press; 1996.
   Google Scholar
• Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford, UK: Oxford University Press; 2001:172–214.
   Google Scholar
• Fenwick E, Claxton K, Schulpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779–787.
   PubMed Web of Science ®Google Scholar